LAMEA Sciatica Treatment Market

LAMEA Sciatica Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Distribution Channel, By Drug Class (Non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others), By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-14099 Publication Date: February-2023 Number of Pages: 90
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Latin America, Middle East and Africa Sciatica Treatment Market would witness market growth of 9.5% CAGR during the forecast period (2022-2028).

Many types of pain may have varying degrees of severity, and various things can trigger them. Therefore, a more drastic course of action could be explored initially for certain patients. In general, however, if a six-week trial of conservative, self-care measures, such as cold, heat, stretching, and over-the-counter medications, hasn't yielded relief, it's time to go back to a doctor and try another course of action. Finding exercise motions that lessen sciatica by relieving pressure on the nerve is the aim of physical therapy.

A fitness regimen should include stretching activities to increase muscular flexibility and cardiovascular workouts (such as walking, swimming, and water aerobics). The medical professionals may suggest a physical therapist who will collaborate to create a stretching and aerobic exercise routine and other exercises to strengthen the legs, back, and belly muscles.

An anti-inflammatory drug called a corticosteroid injection into the lower back may help lessen the discomfort and swelling around the damaged nerve roots. Injections are administered as an outpatient therapy under local anesthetic and provide temporary pain relief (usually lasting up to three months). However, as the injection is being administered, patient may experience pressure and a burning or stinging sensation.

The UAE government has made building a top-notch healthcare infrastructure a primary priority; consequently, the industry has developed and grown tremendously over the last few years. According to the World Health Organization, one in five UAE adults and adults aged 18 and over are obese. These people, backed by relatively high-income levels, will need higher quality healthcare as the prevalence of lifestyle illnesses rises. Over 9.4 million people live in the UAE, and about 85% are foreigners. The UAE government is liberalizing its rules to increase foreign investment and raise the level of healthcare. To make Dubai a regional hub of superior healthcare, the UAE government intends to increase the number of medical tourists visiting the country. These factors will encourage the sciatica treatment market in the LAMEA region to develop.

The Brazil market dominated the LAMEA Sciatica Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $17,047 Thousands by 2028. The Argentina market is experiencing a CAGR of 10.1% during (2022 - 2028). Additionally, The UAE market would showcase a CAGR of 9.2% during (2022 - 2028).

Based on Type, the market is segmented into Chronic, Acute and Others. Based on Distribution Channel, the market is segmented into Retail & Specialty Pharmacies, Hospital Pharmacies and Online Providers. Based on Drug Class, the market is segmented into Non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Sciatica Treatment Market is Projected to reach USD 810.4 Million by 2028, at a CAGR of 3.5%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sorrento Therapeutics, Inc., Alkem Laboratories Ltd., Amneal Pharmaceuticals, Inc., Aurobindo Pharma Limited, Novartis AG, and Cadila Healthcare Ltd. (Zydus Cadila)

Scope of the Study

Market Segments Covered in the Report:

By Type

  • Chronic
  • Acute
  • Others

By Distribution Channel

  • Retail & Specialty Pharmacies
  • Hospital Pharmacies
  • Online Providers

By Drug Class

  • Non-Steroidal anti-inflammatory
  • Steroids
  • Antidepressants
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Sorrento Therapeutics, Inc.
  • Alkem Laboratories Ltd.
  • Amneal Pharmaceuticals, Inc.
  • Aurobindo Pharma Limited
  • Novartis AG
  • Cadila Healthcare Ltd. (Zydus Cadila)
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo